JP2000503010A5 - - Google Patents

Download PDF

Info

Publication number
JP2000503010A5
JP2000503010A5 JP1997524371A JP52437197A JP2000503010A5 JP 2000503010 A5 JP2000503010 A5 JP 2000503010A5 JP 1997524371 A JP1997524371 A JP 1997524371A JP 52437197 A JP52437197 A JP 52437197A JP 2000503010 A5 JP2000503010 A5 JP 2000503010A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP1997524371A
Other languages
English (en)
Other versions
JP2000503010A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US1996/020087 external-priority patent/WO1997024135A1/en
Publication of JP2000503010A publication Critical patent/JP2000503010A/ja
Publication of JP2000503010A5 publication Critical patent/JP2000503010A5/ja
Ceased legal-status Critical Current

Links

Description

Figure 2000503010
Figure 2000503010
Figure 2000503010
Figure 2000503010
Figure 2000503010
Figure 2000503010
Figure 2000503010
Figure 2000503010
Figure 2000503010
Figure 2000503010
Figure 2000503010
Figure 2000503010
Figure 2000503010
Figure 2000503010
Figure 2000503010
JP09524371A 1995-12-29 1996-12-20 アミジノプロテアーゼ阻害剤 Ceased JP2000503010A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US943195P 1995-12-29 1995-12-29
US60/009,431 1995-12-29
PCT/US1996/020087 WO1997024135A1 (en) 1995-12-29 1996-12-20 Amidino protease inhibitors

Publications (2)

Publication Number Publication Date
JP2000503010A JP2000503010A (ja) 2000-03-14
JP2000503010A5 true JP2000503010A5 (ja) 2004-11-04

Family

ID=21737595

Family Applications (1)

Application Number Title Priority Date Filing Date
JP09524371A Ceased JP2000503010A (ja) 1995-12-29 1996-12-20 アミジノプロテアーゼ阻害剤

Country Status (19)

Country Link
US (5) US6034127A (ja)
EP (1) EP0883405B1 (ja)
JP (1) JP2000503010A (ja)
KR (1) KR19990076817A (ja)
AT (1) ATE260112T1 (ja)
BR (1) BR9612360A (ja)
CA (1) CA2256309C (ja)
CZ (1) CZ206698A3 (ja)
DE (1) DE69631692T2 (ja)
DK (1) DK0883405T3 (ja)
ES (1) ES2213786T3 (ja)
HU (1) HUP9902256A3 (ja)
IL (1) IL124883A0 (ja)
MX (1) MX9805152A (ja)
NO (1) NO982987L (ja)
NZ (1) NZ326076A (ja)
PL (1) PL327986A1 (ja)
PT (1) PT883405E (ja)
WO (1) WO1997024135A1 (ja)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT883405E (pt) 1995-12-29 2004-06-30 Dimensional Pharm Inc Inibidores de amidino-protease
SE9602646D0 (sv) 1996-07-04 1996-07-04 Astra Ab Pharmaceutically-useful compounds
TW499412B (en) * 1996-11-26 2002-08-21 Dimensional Pharm Inc Aminoguanidines and alkoxyguanidines as protease inhibitors
AU8270698A (en) 1997-06-26 1999-01-19 Eli Lilly And Company Antithrombotic agents
US6740682B2 (en) 1997-08-29 2004-05-25 Tularik Limited Meta-benzamidine derivatives as serine protease inhibitors
WO1999011658A1 (en) * 1997-08-29 1999-03-11 Proteus Molecular Design Ltd. Meta-benzamidine derivatives as serin protease inhibitors
DE69941224D1 (de) * 1998-11-20 2009-09-17 Fuso Pharmaceutical Ind Nachweismethode für pankreatitis
AR023510A1 (es) 1999-04-21 2002-09-04 Astrazeneca Ab Un equipo de partes, formulacion farmaceutica y uso de un inhibidor de trombina.
US6586617B1 (en) 1999-04-28 2003-07-01 Sumitomo Chemical Takeda Agro Company, Limited Sulfonamide derivatives
JP2001026506A (ja) * 1999-04-28 2001-01-30 Takeda Chem Ind Ltd スルホンアミド誘導体
US6635637B2 (en) 2000-08-04 2003-10-21 Dimensional Pharmaceuticals, Inc. Cyclic oxyguanidine protease inhibitors
WO2002038108A2 (en) * 2000-11-03 2002-05-16 The J. David Gladstone Institutes Methods of treating disorders related to apoe
US8394813B2 (en) 2000-11-14 2013-03-12 Shire Llc Active agent delivery systems and methods for protecting and administering active agents
PT1383756E (pt) * 2001-04-24 2008-06-19 Aryx Therapeutics Derivados de cumarina a utilizar como anticoagulantes
AU2003302238A1 (en) 2002-12-03 2004-06-23 Axys Pharmaceuticals, Inc. 2-(2-hydroxybiphenyl-3-yl)-1h-benzoimidazole-5-carboxamidine derivatives as factor viia inhibitors
EP1751091A2 (en) * 2004-03-25 2007-02-14 Elan Pharmaceuticals, Inc. 2-amino- and 2-thio-substituted 1,3-diaminopropanes
GB0815781D0 (en) * 2008-08-29 2008-10-08 Xention Ltd Novel potassium channel blockers
GB0815782D0 (en) 2008-08-29 2008-10-08 Xention Ltd Novel potassium channel blockers
GB0815784D0 (en) * 2008-08-29 2008-10-08 Xention Ltd Novel potassium channel blockers
RU2019121905A (ru) * 2010-12-31 2019-09-03 Астразенека Юкей Лимитед Ингибиторы аргиназы и способы их применения
EP2989080A1 (en) * 2013-04-22 2016-03-02 Reuter Chemische Apparatebau KG Process for preparing enantiomerically enriched 3-hydroxymethylpiperidine

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3577432A (en) * 1968-12-23 1971-05-04 Robins Co Inc A H 1-substituted-3-phenoxypyrrolidines
CH526535A (de) 1970-02-05 1972-08-15 Sandoz Ag Verfahren zur Herstellung neuer Pyrrolidin-1-carboxamidinderivate
JPS537436B2 (ja) * 1974-04-16 1978-03-17
JPS5175042A (ja) * 1974-12-26 1976-06-29 Ono Pharmaceutical Co Guanijinoshibosanamidojudotaino seizohoho
HU177098B (en) * 1979-01-04 1981-07-28 Gyogyszerkutato Intezet Process for producing new peptidyl-n-carboxy-l-arginin-a
US4316899A (en) 1979-08-24 1982-02-23 Beecham Group Limited Chromanone derivatives, a process for their preparation and compositions containing them
US4433152A (en) * 1981-05-25 1984-02-21 Nippon Chemiphar Co., Ltd. Amidinopiperidine derivatives
JPS58194861A (ja) * 1982-05-10 1983-11-12 Nippon Chemiphar Co Ltd 新規ピペリジン誘導体およびその製造法
JPS62145060A (ja) 1985-12-17 1987-06-29 Tanabe Seiyaku Co Ltd ピペラジン誘導体及びその製法
US5039805A (en) * 1988-12-08 1991-08-13 Hoffmann-La Roche Inc. Novel benzoic and phenylacetic acid derivatives
DE3913597A1 (de) 1989-04-25 1990-11-08 Heumann Pharma Gmbh & Co Diazinderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
TW201303B (ja) * 1990-07-05 1993-03-01 Hoffmann La Roche
DE4127404A1 (de) 1991-08-19 1993-02-25 Thomae Gmbh Dr K Cyclische iminoderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
CA2427890A1 (en) 1992-02-05 1993-08-19 Ralf Anderskewitz New amidine derivatives, the preparation and use thereof
TW223629B (ja) * 1992-03-06 1994-05-11 Hoffmann La Roche
TW257757B (ja) * 1993-03-03 1995-09-21 Boehringer Mannheim Gmbh
US5466811A (en) * 1994-07-18 1995-11-14 Merck & Co., Inc. Dioxolenylmethyl carbamates pro moieties for amine drugs
DE4430755A1 (de) * 1994-08-30 1996-03-07 Boehringer Mannheim Gmbh Neue Phosphanoxide, Verfahren zu ihrer Herstellung sowie diese Verbindungen enthaltende Arzneimittel
DE4430757A1 (de) * 1994-08-30 1996-03-07 Boehringer Mannheim Gmbh Neue 4-Aminopyridazine, Verfahren zu ihrer Herstellung sowie diese Verbindungen enthaltende Arzneimittel
CA2233344A1 (en) * 1995-09-29 1997-04-03 3-Dimensional Pharmaceuticals, Inc. Guanidino protease inhibitors
PT883405E (pt) 1995-12-29 2004-06-30 Dimensional Pharm Inc Inibidores de amidino-protease

Similar Documents

Publication Publication Date Title
JP2000500228A5 (ja)
JP2000500445A5 (ja)
JP2000500440A5 (ja)
JP2000500327A5 (ja)
JP2000500145A5 (ja)
JP2000500155A5 (ja)
JP2000500406A5 (ja)
JP2000500361A5 (ja)
JP2001508514A5 (ja)
JP2000500115A5 (ja)
JP2000500649A5 (ja)
JP2000501752A5 (ja)
JP2000500322A5 (ja)
JP2000500258A5 (ja)
JP2000500342A5 (ja)
JP2000500192A5 (ja)
JP2000500112A5 (ja)
JP2000500397A5 (ja)
JP2000500226A5 (ja)
JP2000500407A5 (ja)
JP2000500166A5 (ja)
JP2000500125A5 (ja)
JP2000500257A5 (ja)
JP2000500090A5 (ja)
JP2000500346A5 (ja)